Literature DB >> 1721788

Age- and sex-related study of HBV-DNA in HBsAg asymptomatic children from an endemic area (Cameroon).

M Rapicetta1, T Stroffolini, T Ngatchu, P Chionne, A R Ciccaglione, D Lantum, M Chiaramonte.   

Abstract

A sero-epidemiological survey was carried out in Cameroon in January 1989 on a sample of 702 children of primary school age. A high HBV endemicity level was observed: 60.3% of the sera were positive to any HBV marker, 23.2% (163 sera) were HBsAg-positive. HBV-DNA positivity was observed in 38/163 (23.3%), thus showing a high level of infectivity among these carriers. Seventy-seven HBsAg-positive sera were tested for HBeAg/anti-HBe: 20 (26%) were HBeAg-positive 31 (40%) anti-HBe-positive, and 26 (34%) were negative for both. All sera were anti-HD-negative. Twenty-five per cent of HBeAg-positive sera were HBV-DNA-negative. This finding could be explained by a delayed HBeAg/anti-HBe seroconversion phase with fluctuant HBV-DNA. Only one case of HBV-DNA-positive anti-HBe-positive serum was observed. This study showed that HBV-DNA prevalence was significantly higher in boys (31.8%) than in girls (14.1%) (p less than 0.02). This difference was not observed for any HBV marker. We therefore conclude that in boys a prolonged HBV replicative phase might explain the observed high chronicity rate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721788     DOI: 10.1080/02724936.1991.11747523

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  2 in total

1.  Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus.

Authors:  Elizabeth J Theve; Yan Feng; Koli Taghizadeh; Kathleen S Cormier; David R Bell; James G Fox; Arlin B Rogers
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

Review 2.  The status of hepatitis B control in the African region.

Authors:  Lucy Breakwell; Carol Tevi-Benissan; Lana Childs; Richard Mihigo; Rania Tohme
Journal:  Pan Afr Med J       Date:  2017-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.